Pierre-Olivier Fernagut
Pierre-Olivier Fernagut
Institut des maladies neurodégénératives CNRS UMR5293, Université de Bordeaux
Verified email at u-bordeaux.fr
TitleCited byYear
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming, J Salcedo, PO Fernagut, E Rockenstein, E Masliah, ...
Journal of Neuroscience 24 (42), 9434-9440, 2004
4112004
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys
A Recasens, B Dehay, J Bové, I Carballo‐Carbajal, S Dovero, ...
Annals of neurology 75 (3), 351-362, 2014
3762014
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
V Voon, PO Fernagut, J Wickens, C Baunez, M Rodriguez, N Pavon, ...
The Lancet Neurology 8 (12), 1140-1149, 2009
3302009
Direct regulation of adult brain function by the male-specific factor SRY
P Dewing, CWK Chiang, K Sinchak, H Sim, PO Fernagut, S Kelly, ...
Current Biology 16 (4), 415-420, 2006
3012006
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ...
Progress in neurobiology 132, 96-168, 2015
2432015
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone
SM Fleming, C Zhu, PO Fernagut, A Mehta, CD DiCarlo, RL Seaman, ...
Experimental neurology 187 (2), 418-429, 2004
1992004
Genetic mouse models of parkinsonism: strengths and limitations
SM Fleming, PO Fernagut, MF Chesselet
NeuroRx 2 (3), 495-503, 2005
1792005
Alpha-synuclein and transgenic mouse models
PO Fernagut, MF Chesselet
Neurobiology of disease 17 (2), 123-130, 2004
1792004
Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expression
PO Fernagut, CB Hutson, SM Fleming, NA Tetreaut, J Salcedo, E Masliah, ...
Synapse 61 (12), 991-1001, 2007
1782007
A simple method to measure stride length as an index of nigrostriatal dysfunction in mice
PO Fernagut, E Diguet, B Labattu, F Tison
Journal of neuroscience methods 113 (2), 123-130, 2002
1752002
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
E Diguet, PO Fernagut, X Wei, Y Du, R Rouland, C Gross, E Bezard, ...
European Journal of Neuroscience 19 (12), 3266-3276, 2004
1642004
Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation
PO Fernagut, E Diguet, N Stefanova, M Biran, GK Wenning, P Canioni, ...
Neuroscience 114 (4), 1005-1017, 2002
1432002
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?
F Bassil, PO Fernagut, E Bezard, WG Meissner
Progress in neurobiology 118, 1-18, 2014
1352014
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
V Voon, TC Napier, MJ Frank, V Sgambato-Faure, AA Grace, ...
The Lancet Neurology 16 (3), 238-250, 2017
1112017
Variable effects of chronic subcutaneous administration of rotenone on striatal histology
C Zhu, P Vourc'h, PO Fernagut, SM Fleming, S Lacan, CD Dicarlo, ...
Journal of Comparative Neurology 478 (4), 418-426, 2004
882004
Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice
PO Fernagut, S Chalon, E Diguet, D Guilloteau, F Tison, M Jaber
Neuroscience 116 (4), 1123-1130, 2003
872003
Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome
AP Chou, N Maidment, R Klintenberg, JE Casida, S Li, AG Fitzmaurice, ...
Journal of Biological Chemistry 283 (50), 34696-34703, 2008
742008
Impact of high-frequency stimulation parameters on the pattern of discharge of subthalamic neurons
L Garcia, G d'Alessandro, PO Fernagut, B Bioulac, C Hammond
Journal of neurophysiology 94 (6), 3662-3669, 2005
722005
Selective inactivation of striatal FosB/ΔFosB-expressing neurons alleviates L-DOPA–induced dyskinesia
M Engeln, MF Bastide, E Toulmé, B Dehay, M Bourdenx, E Doudnikoff, ...
Biological psychiatry 79 (5), 354-361, 2016
642016
Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia
MF Bastide, S Dovero, G Charron, G Porras, CE Gross, PO Fernagut, ...
Neurobiology of disease 62, 179-192, 2014
592014
The system can't perform the operation now. Try again later.
Articles 1–20